nefrНефрологияNephrology (Saint-Petersburg)1561-62742541-9439Pavlov First Saint-Petersburg State Medical University10.36485/1561-6274-2020-24-6-40-54nefr-1900Research ArticleОРИГИНАЛЬНЫЕ СТАТЬИ. КЛИНИЧЕСКИЕ ИССЛЕДОВАНИЯORIGINAL ARTICLES. CLINICAL INVESTIGATIONSКлинико-морфологическая презентация люпус-нефрита (одноцентровое исследование 157 случаев)Clinical and morphological presentation of lupus nephritis: a single-center study of 157 caseshttps://orcid.org/0000-0002-7179-5520ДобронравовВ. А.DobronravovV. A.

Проф. Добронравов Владимир Александрович, д-р мед. наук, заместитель директора по научной работе научноисследовательского института нефрологии, профессор кафедры пропедевтики внутренних болезней с клиникой

197022, Санкт-Петербург, ул. Л. Толстого, д. 17, корп. 54Тел.: +7(812)338-69-01 

Prof. Vladimir A. Dobronravov, MD, PhD, DSc, Research Institute of Nephrology, Deputy Director for Research; Department of Propedeutics of Internal Diseases with the Clinic, Professor

197022, Saint Petersburg, L. Tolstoy st., 17, build. 54Phone: +7(812)338-69-01 

dobronravov@nephrolog.ruhttps://orcid.org/0000-0003-0758-8137КаруннаяА. В.KarunnayaA. V.

Карунная Анна Викторовна, врач-нефролог, научно-исследовательский институт нефрологии, врач-нефролог отделения хронического гемодиализа, ассистент кафедры пропедевтики внутренних болезней с клиникой

197022, Санкт-Петербург, ул. Л. Толстого, д. 17, корп. 54Тел.: +7(812)338-69-14 

Anna V. Karunnaya, MD, Research Institute of Nephrology, Department of Chronic Hemodialysis, nephrologist, Department of Propaedeutics of Internal Diseases with the Clinic, assistant

197022, Saint Petersburg, L. Tolstoy st., 17, build. 54Phone: +7(812)338-69-14 

a.v.karunnaya@yandex.ruhttps://orcid.org/0000-0002-1512-8037СиповскийВ. Г.SipovskiiV. G.

Сиповский Василий Георгиевич, канд. мед. наук, заведующий лабораторией клинической иммунологии и морфологии научно-исследовательского института нефрологии

197022, Россия, Санкт-Петербург, ул. Л. Толстого, д. 17, корп. 54Тел.: +7(921)754-20-34 

Vassili G. Sipovskii, MD, PhD, Research Institute of Nephrology, Head of the Laboratory of Clinical Immunology and Morphology

sipovski@mail.ruПервый Санкт-Петербургский государственный медицинский университет имени академика И.П. ПавловаРоссияPavlov UniversityRussian Federation2020251120202464054Copyright © Добронравов В.А., Карунная А.В., Сиповский В.Г., 20202020Добронравов В.А., Карунная А.В., Сиповский В.Г.Dobronravov V.A., Karunnaya A.V., Sipovskii V.G.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.nephrolog.ru/jour/article/view/1900системная красная волчанкалюпус-нефритволчаночная подоцитопатиягломерулонефритклинические проявленияморфологическая диагностикаиммуноморфологияморфологияклинико-морфологические корреляциинекротизирующий люпус-нефритполулунияsystemic lupus erythematosuslupus nephritislupus podocytopathyglomerulonephritisclinical manifestationmorphological diagnosticsimmunomorphologymorphologyclinical and morphological correlationsnecrotizing lupus nephritiscrescentsReferencesHanly JG, O'Keeffe AG, Su L et al. The frequency and outcome of lupus nephritis: results from an international inception cohort study. Rheumatology (Oxford) 2016;55(2):252-262. doi: 10.1093/rheumatology/kev311Hanly JG, O'Keeffe AG, Su L et al. The frequency and outcome of lupus nephritis: results from an international inception cohort study. Rheumatology (Oxford) 2016;55(2):252-262. doi: 10.1093/rheumatology/kev311Wang H, Ren Y-L, Chang J et al. A systematic review and meta-analysis of prevalence of biopsy-proven lupus nephritis. Arch Rheumatol 2018;33(1):17-25. doi: 10.5606/archrheumatol.2017.6127Wang H, Ren Y-L, Chang J et al. A systematic review and meta-analysis of prevalence of biopsy-proven lupus nephritis. Arch Rheumatol 2018;33(1):17-25. doi: 10.5606/archrheumatol.2017.6127Mahajan A, Amelio J, Gairy K et al. Systemic lupus erythematosus, lupus nephritis and end-stage renal disease: a pragmatic review mapping disease severity and progression. Lupus 2020;29(9):1011-1020. doi: 10.1177/0961203320932219Mahajan A, Amelio J, Gairy K et al. Systemic lupus erythematosus, lupus nephritis and end-stage renal disease: a pragmatic review mapping disease severity and progression. Lupus 2020;29(9):1011-1020. doi: 10.1177/0961203320932219Yu F, Haas M, Glassock R, Zhao M-H. Redefining lupus nephritis: clinical implications of pathophysiologic subtypes. Nat Rev Nephrol 2017;13(8):483-495. doi: 10.1038/nrneph.2017.85Yu F, Haas M, Glassock R, Zhao M-H. Redefining lupus nephritis: clinical implications of pathophysiologic subtypes. Nat Rev Nephrol 2017;13(8):483-495. doi: 10.1038/nrneph.2017.85Tektonidou MG, Dasgupta A, Ward MM. Risk of endstage renal disease in patients with lupus nephritis, 1971–2015: a systematic review and Bayesian meta-analysis. Arthritis Rheum 2016;68:1432-1441. doi: 10.1002/art.39594Tektonidou MG, Dasgupta A, Ward MM. Risk of endstage renal disease in patients with lupus nephritis, 1971–2015: a systematic review and Bayesian meta-analysis. Arthritis Rheum 2016;68:1432-1441. doi: 10.1002/art.39594Weening JJ, D'Agati VD, Schwartz MM et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int 2004;65(2):521-530. doi: 10.1111/j.15231755.2004.00443.xWeening JJ, D'Agati VD, Schwartz MM et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int 2004;65(2):521-530. doi: 10.1111/j.15231755.2004.00443.xKidney Disease: Improving Global Outcomes (KDIGO) Glomerulonephritis Work Group. KDIGO Clinical Practice Guideline for Glomerulonephritis. Kidney Inter 2012;2:139-274Kidney Disease: Improving Global Outcomes (KDIGO) Glomerulonephritis Work Group. KDIGO Clinical Practice Guideline for Glomerulonephritis. Kidney Inter 2012;2:139-274Ассоциация ревматологов России. Клинические рекомендации по диагностике и лечению системной красной волчанки. https://rheumatolog.ru/experts/klinicheskierekomendaciiAssociation of rheumatologists of Russia. Clinical practice guidelines for the diagnosis and treatment of systemic lupus erythematosus. https://rheumatolog.ru/experts/klinicheskierekomendacii (In Russ.)Fanouriakis A, Kostopoulou M, Cheema K et al. 2019 Update of the Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ ERA–EDTA) recommendations for the management of lupus nephritis. Ann Rheum Dis 2020;79:713-723. doi: 10.1136/annrheumdis-2020-216924Fanouriakis A, Kostopoulou M, Cheema K et al. 2019 Update of the Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ ERA–EDTA) recommendations for the management of lupus nephritis. Ann Rheum Dis 2020;79:713-723. doi: 10.1136/annrheumdis-2020-216924Тареева ИЕ. Варианты течения волчаночного нефрита. Клиническая нефрология 2011;2:5-8Tareeva IE. Variants of the lupous nephritis course. Clinical Nephrology 2011;2:5-8Михайлова НА, Захарова ЕВ, Ипатьева ЕИ и соавт. Системная красная волчанка с поражением почек: клиническая характеристика и опыт лечения в нефрологическом отделении ГКБ им. С.П. Боткина за период с 1991 по 2001 гг. Нефрология и диализ 2002;4(3):186-191Mikhailova NA, Zakharova EV, Ipatieva EI et al. Systemic Lupus Erythematosus with renal involvement: clinical features and experience of treatment in the Division of Nephrology of Botkin City hospital (1991-2001). Nephrology and dialysis 2002;4(3):186-191Захарова ЕВ. Волчаночный гломерулонефрит: клиника, морфология, прогноз. Нефрология и диализ 2003;5(2):116-122Zakharova EV. Lupus glomerulonephritis: clinical features, morphology and prognosis. Nephrology and dialysis 2003;5(2):116-122Захарова ЕВ, Ипатьева ЕИ, Тареева ЕИ и соавт. Особенности течения и прогностические факторы неблагоприятных исходов системной красной волчанки и системных васкулитов с поражением почек. Нефрология и диализ 2006; 8(2):128-140Zakharova EV, Ipatjeva EI, Tareeva EI et al. Clinical course and predictors of death and esrd in patients with systemic lupus erythematosus and systemic vasculitis with kidney involvement. Nephrology and dialysis 2006;8(2):128-140Арзиманова НА, Марасаев ВВ, Абиссова ТО. Иммуноморфологические особенности гломерулярного и тубулоинтерстициального поражения почек у больных системной красной волчанкой. Научно-практическая ревматология 2009;47(2):17-22. doi: 10.14412/1995-4484-2009-454Arzimanova NA, Marasaev VV, Abissova TO. Immuno-morphological features of glomerular and tubulointerstitial kidney damage in patients with systemic lupus erythematosus. Rheumatology Science and Practice 2009;47(2):17-22. (In Russ.) doi: 10.14412/1995-4484-2009-454Торгашина АВ, Соловьев СК, Александрова ЕН и др. Применение ритуксимаба у больных волчаночным нефритом. Научно-практическая ревматология 2010;48(4):14-26. doi: 10.14412/1995-4484-2010-1161Torgashina AV, Solovyev SK, Aleksandrova EN et al. Use of rituximab in patients with lupus nephritis. Rheumatology Science and Practice 2010;48(4):14-26. (In Russ.) doi: 10.14412/19954484-2010-1161Козловская НЛ, Шилов ЕМ, Метелев НА и др. Клинические и морфологические особенности волчаночного нефрита при системной красной волчанке с антифосфолипидным синдромом. Терапевтический архив 2006;78(5):21-31Kozlovskaya NL, Shilov EM, Metelev NA et al. Clinical and morphological characteristics of lupus nephritis in systemic lupus erythematosus with antiphospholipid syndrome. Terapevticheskiy arkhiv 2006;78(5):21-31Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725. doi: 10.1002/art.1780400928Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725. doi: 10.1002/art.1780400928Bombardier C, Gladman DD, Urowitz MB et al. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthr Rheum 1992;35:630-640. doi: 10.1002/art.1780350606Bombardier C, Gladman DD, Urowitz MB et al. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthr Rheum 1992;35:630-640. doi: 10.1002/art.1780350606Christopher-Stine L, Siedner M, Lin J et al. Renal biopsy in lupus patients with low levels of proteinuria. J Rheumatol 2007;34:332-335Christopher-Stine L, Siedner M, Lin J et al. Renal biopsy in lupus patients with low levels of proteinuria. J Rheumatol 2007;34:332-335Wakasugi D, Gono T, Kawaguchi Y et al. Frequency of class III and IV nephritis in systemic lupus erythematosus without clinical renal involvement: an analysis of predictive measures. J Rheumatol 2012;39:79-85. doi: 10.3899/jrheum.110532Wakasugi D, Gono T, Kawaguchi Y et al. Frequency of class III and IV nephritis in systemic lupus erythematosus without clinical renal involvement: an analysis of predictive measures. J Rheumatol 2012;39:79-85. doi: 10.3899/jrheum.110532De Rosa M, Rocha AS, Graciela De Rosa G and al. Low-Grade Proteinuria Does Not Exclude Significant Kidney Injury in Lupus Nephritis. Kidney Int Rep 2020;13;5(7):1066-1068. doi: 10.1016/j.ekir.2020.04.005De Rosa M, Rocha AS, Graciela De Rosa G and al. Low-Grade Proteinuria Does Not Exclude Significant Kidney Injury in Lupus Nephritis. Kidney Int Rep 2020;13;5(7):1066-1068. doi: 10.1016/j.ekir.2020.04.005Feng Yu F, Tan Y, Gang Liu G et al. Clinicopathological characteristics and outcomes of patients with crescentic lupus nephritis. Kidney Int 2009;76(3):307-317. doi: 10.1038/ki.2009.136Feng Yu F, Tan Y, Gang Liu G et al. Clinicopathological characteristics and outcomes of patients with crescentic lupus nephritis. Kidney Int 2009;76(3):307-317. doi: 10.1038/ki.2009.136Alsuwaida A, Husain S, Ghonaim MAl et al. Glomerular necrotic lesions and long-term outcomes among patients with proliferative lupus nephritis. Int J Clin Exp Pathol 2015;8(5):57875792Alsuwaida A, Husain S, Ghonaim MAl et al. Glomerular necrotic lesions and long-term outcomes among patients with proliferative lupus nephritis. Int J Clin Exp Pathol 2015;8(5):57875792Zhang W, Yuan M, Hong L et al. Clinical outcomes of lupus nephritis patients with different proportions of crescents. Lupus 2016;25(14):1532-1541. doi: 10.1177/0961203316642312Zhang W, Yuan M, Hong L et al. Clinical outcomes of lupus nephritis patients with different proportions of crescents. Lupus 2016;25(14):1532-1541. doi: 10.1177/0961203316642312Tao J, Wang H, Wang S-X et al. The predictive value of crescents in the disease progression of lupus nephritis based on the 2018 International Society of Nephrology/Renal Pathology Society Revision System: a large cohort study from China. Renal Failure 2020;42(1):166-172. doi: 10.1080/0886022X.2020.1726385Tao J, Wang H, Wang S-X et al. The predictive value of crescents in the disease progression of lupus nephritis based on the 2018 International Society of Nephrology/Renal Pathology Society Revision System: a large cohort study from China. Renal Failure 2020;42(1):166-172. doi: 10.1080/0886022X.2020.1726385Bajema IM, Wilhelmus S, Alpers CE et al. Revision of the International Society of Nephrology/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices. Kidney Int 2018;93(4):789-796. doi: 10.1016/j.kint.2017.11.023Bajema IM, Wilhelmus S, Alpers CE et al. Revision of the International Society of Nephrology/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices. Kidney Int 2018;93(4):789-796. doi: 10.1016/j.kint.2017.11.023Bomback AS, Markowitz GS. Lupus Podocytopathy: A Distinct Entity. Clin J Am Soc Nephrol 2016;11(4):547-548. doi: 10.2215/CJN.01880216Bomback AS, Markowitz GS. Lupus Podocytopathy: A Distinct Entity. Clin J Am Soc Nephrol 2016;11(4):547-548. doi: 10.2215/CJN.01880216Sakhi H, Moktefi A, Bouachi K et al. Podocyte Injury in Lupus Nephritis. J Clin Med 2019;8(9):1340. doi: 10.3390/jcm8091340Sakhi H, Moktefi A, Bouachi K et al. Podocyte Injury in Lupus Nephritis. J Clin Med 2019;8(9):1340. doi: 10.3390/jcm8091340Hu W, Chen Y, Wang Sh et al. Clinical-Morphological Features and Outcomes of Lupus Podocytopathy. Clin J Am Soc Nephrol 2016 Apr 7;11(4):585-592. doi: 10.2215/CJN.06720615Hu W, Chen Y, Wang Sh et al. Clinical-Morphological Features and Outcomes of Lupus Podocytopathy. Clin J Am Soc Nephrol 2016 Apr 7;11(4):585-592. doi: 10.2215/CJN.06720615Tektonidou MG, Sotsiou F, Nakopoulou L et al. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome. Arthritis Rheum 2004;50(8):2569-2579. doi: 10.1002/art.20433Tektonidou MG, Sotsiou F, Nakopoulou L et al. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome. Arthritis Rheum 2004;50(8):2569-2579. doi: 10.1002/art.20433

The authors declare that there are no conflicts of interest present.